ZVIA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Zevia PBC (ZVIA) is not a strong buy at the moment for a beginner investor with a long-term focus and $50,000-$100,000 available for investment. The stock has mixed technical indicators, weak financial performance, and no significant positive catalysts currently. While there is some potential for long-term growth, the lack of strong trading signals, weak analyst sentiment, and declining financials make it prudent to hold off on investing in this stock right now.
The MACD is positive and expanding, indicating a bullish trend. However, the RSI is neutral at 67, and moving averages are converging, suggesting no clear direction. The stock is trading near its resistance levels (R1: 1.265, R2: 1.296), which may limit further upward movement in the short term.
The company is making progress on its turnaround strategy, as noted by analysts, and is set to release Q1 2026 financial results soon, which could provide more clarity on its performance. Zevia's distribution in over 39,000 retail locations across the U.S. and Canada indicates a strong market presence.
Analysts have lowered price targets, and the stock has a 70% chance of declining by -1.56% in the next day. There are no significant hedge fund or insider trading trends, and no recent congress trading data is available.
In Q4 2025, Zevia reported a revenue decline of -4.03% YoY to $37.87 million. Net income dropped sharply by -77.25% YoY to -$1.31 million, and EPS fell by -80.00% YoY to -0.02. Gross margin also declined slightly to 47.27%, down -2.50% YoY, indicating weakening profitability.
Analysts have a mixed to negative sentiment on the stock. Morgan Stanley lowered its price target to $1.75 from $2.90 and maintained an Equal Weight rating. Telsey Advisory lowered its target to $5 from $6 but maintained an Outperform rating, citing progress on the company's turnaround. Goldman Sachs lowered its target to $3 from $3.50 and kept a Neutral rating.
